| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 12/16/2009 | CN101601793A Manufacturing method of qi-blood recovery medicine |
| 12/16/2009 | CN101601777A Preparation method of powder for quickly eliminating jiugu |
| 12/16/2009 | CN101601776A Preparation method of medicine for quickly draining intravascular thrombosis |
| 12/16/2009 | CN101601773A Manufacturing method of tortoise plastron glue tonic wine |
| 12/16/2009 | CN101601727A Thrombus-dredging wine drug |
| 12/16/2009 | CN101601711A Preparation method of soup for curing frequent urination and enuresis |
| 12/16/2009 | CN101601690A Preparation method of soup for quickly loosening bowels |
| 12/16/2009 | CN101601660A Soluble tablet containing clopidogrel |
| 12/16/2009 | CN101601659A Glutathione enteric-coated pellet and preparation method thereof |
| 12/16/2009 | CN101601656A Edaravone liposome injection and new application thereof |
| 12/16/2009 | CN101601647A Riboflavine sodium phosphate composition injection and preparation method thereof |
| 12/16/2009 | CN101601643A Skeleton hemostasis gel |
| 12/16/2009 | CN101601468A Preparation method of wolfberry fruit and broomrape tonic wine |
| 12/16/2009 | CN100569658C Sodium zirconium carbonate and zirconium basic carbonate and methods of making the same |
| 12/16/2009 | CN100569281C Preparation and use of compositions for treating and preventing necrosis |
| 12/16/2009 | CN100569278C Chinese medicine combination for activating blood circulation and treating thrombus |
| 12/16/2009 | CN100569275C Oil-solvent extraction of ginger extract |
| 12/16/2009 | CN100569114C Crocodile meat preparation and production process thereof |
| 12/15/2009 | US7632817 Antibodies against exogeneous protein; epitopes different from those detected by antibodies; myasthenia gravis; infertility; gene therapy |
| 12/15/2009 | US7632677 Cell line expressing mutated human tissue-type plasminogen activator, the constructing strategy thereof and method of preparing expressed protein |
| 12/15/2009 | CA2525854C Acylsulfamide inhibitors of factor viia |
| 12/15/2009 | CA2422698C Indoline derivatives and their use as 5-ht2 receptor ligands |
| 12/15/2009 | CA2373180C Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
| 12/15/2009 | CA2348445C Compositions for the treatment and prevention of cardiovascular diseases |
| 12/15/2009 | CA2312164C Antioxidant activity in sdg metabolites |
| 12/15/2009 | CA2248960C Stable factor viii/vwf-complex |
| 12/10/2009 | WO2009147529A1 Substantially pure deferasirox and processes for the preparation thereof |
| 12/10/2009 | WO2009147418A1 Substituted quinazolines |
| 12/10/2009 | WO2009147178A2 Novel medical use of substituted pyridin-2-ylmethylsulphinyl-1h-benzimidazoles |
| 12/10/2009 | WO2009146802A1 Macrocyclic urea and sulfamide derivatives as inhibitors of tafia |
| 12/10/2009 | WO2009114090A3 Method for inhibiting the build-up of arterial plaque by administering fullerenes |
| 12/10/2009 | WO2009095163A3 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals |
| 12/10/2009 | US20090306211 Peritoneal dialysis fluid |
| 12/10/2009 | US20090306209 Enteric-coated formulations of polyethylene glycol and one or more soluble amino acids for oral ingestion and enhanced uptake of same |
| 12/10/2009 | US20090306208 Prophylactic or therapeutic composition for hemoglobinuria or myoglobinuria |
| 12/10/2009 | US20090306186 Novel tissue protective erythropoietin receptor (nepor) and methods of use |
| 12/10/2009 | US20090306139 Heteroaryl-substituted piperidines |
| 12/10/2009 | US20090306079 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 12/10/2009 | US20090306069 Azolidinone-vinyl fused-benzene derivatives |
| 12/10/2009 | US20090306059 Cyclic amine derivative having substituted alkyl group |
| 12/10/2009 | US20090306058 Sulphone Derivatives for Treatment of Cancer |
| 12/10/2009 | US20090306019 Compositions for treatment of eosinophilia and related disorders |
| 12/10/2009 | US20090306002 Iron metabolism-improving agent |
| 12/10/2009 | US20090305991 33 Human Secreted Proteins |
| 12/10/2009 | US20090305967 Glycopegylated factor vii and factor viia |
| 12/10/2009 | US20090305966 Use of histones for therapeutic purposes |
| 12/10/2009 | US20090305963 Lipocalin 2 for the Treatment, Prevention, and Management of Cancer Metastasis, Angiogenesis, and Fibrosis |
| 12/10/2009 | US20090305365 Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof |
| 12/10/2009 | US20090304804 Biologic devices for hemostasis |
| 12/10/2009 | US20090304652 Identification and selection of stem cells being committed to differentiate to a specific type for obtaining a homogeneous population of stem cells |
| 12/10/2009 | US20090304628 Stabilized pharmaceutical formulations that contain the interferons gamma and alpha in synergistic proportions |
| 12/10/2009 | DE10222561B4 Protektive Lösung zur Verhinderung von Ischämieschäden Protective solution for preventing ischemic damage |
| 12/10/2009 | DE102009012465A1 Pharmazeutische Zusammensetzung zur Prophylaxe und Behandlung der Arteriosklerose, sowie zur Schmerzbekämpfung und zur Entzündungshemmung A pharmaceutical composition for the prophylaxis and treatment of atherosclerosis, as well as pain relief and inflammation |
| 12/10/2009 | CA2726942A1 Fviii muteins for treatment of von willebrand disease |
| 12/10/2009 | CA2726554A1 Macrocyclic urea and sulfamide derivatives as inhibitors of tafia |
| 12/10/2009 | CA2724376A1 Substituted quinazolines |
| 12/09/2009 | EP2130554A1 Novel albumin-free factor VIII formulations |
| 12/09/2009 | EP2129653A2 Novel p2y12 receptor antagonists |
| 12/09/2009 | EP2129379A1 Imidazoquinolines as dual lipid kinase and mtor inhibitors |
| 12/09/2009 | EP2129378A1 Therapeutic compositions |
| 12/09/2009 | EP1735296B1 Materials and methods for treating coagulation disorders |
| 12/09/2009 | EP1722802B1 A medical solution, a method for producing said medical solution and use thereof |
| 12/09/2009 | EP1458754B1 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control |
| 12/09/2009 | EP1252144B1 Substituted glutarimides and use thereof il-12 production inhibitors |
| 12/09/2009 | CN101600721A A process for the preparation of polymorph form i of (s)-(+)-methyl-a-(2-chlorophenyl)-6,7-dyhidro-thieno-[3,2-c]pyridine-5(4h)-acetate hydrogen sulfate |
| 12/09/2009 | CN101600446A Cellular preparations for use as a revascularisation stimulating agent |
| 12/09/2009 | CN101600431A Pharmaceutical composition having improved storage stability |
| 12/09/2009 | CN101600430A Solid medicinal preparation containing mannitol or lactose |
| 12/09/2009 | CN101597600A Solid fermentation method of nattokinase |
| 12/09/2009 | CN101597595A Bi-functional monoclonal antibody capable of anti-human von willbrand factor-A3 |
| 12/09/2009 | CN101597337A Conjugate of hydroxyalkyl starch and an active agent |
| 12/09/2009 | CN101597322A 17 analogs of Tyr-Ile-Gly-Ser-Arg as well as synthetic method and application thereof in medicine |
| 12/09/2009 | CN101596311A Stable kallikrein-1 injection |
| 12/09/2009 | CN101596292A Oral liquid for tonifying spleen and beautifying |
| 12/09/2009 | CN101596222A Refined ginkgo biloba extract, powder and preparation method thereof |
| 12/09/2009 | CN101596221A Process for preparing water-soluble ginkgo biloba extract used for injection |
| 12/09/2009 | CN101596218A RuBaiShu wound liquid |
| 12/09/2009 | CN101596206A Drug combination for treating anemia |
| 12/09/2009 | CN101596201A Application of ergot sterone in preparation of diuresis medicine |
| 12/09/2009 | CN101596167A New preparation method of Ozagrel sodium powder injection |
| 12/09/2009 | CN101596166A Aspirin enteric-coated pellet |
| 12/09/2009 | CN101596001A Natural egg for activating blood and nourishing the heart and preparation method thereof |
| 12/09/2009 | CN101595989A Blood-enriching face-nourishing medicated porridge |
| 12/09/2009 | CN100567490C RNA interference fragment and its use |
| 12/09/2009 | CN100567488C Enhancement of virus-mediated DNA transfer |
| 12/09/2009 | CN100567487C Coagulation factor VII derivatives |
| 12/09/2009 | CN100567483C FAD4, FAD5, FAD5-2 and FAD6 fatty acid desaturase enzyme family members and uses thereof |
| 12/09/2009 | CN100566710C New use of 6,7-dehydroroyleanone in pharmaceutical |
| 12/09/2009 | CN100566703C Plaster for promoting peristalsis and urination after operation |
| 12/09/2009 | CN100566598C Health-care product containing young bamboo powder for treating hypohemia and its preparing method |
| 12/08/2009 | US7629377 e.g. 1-Benzyl-3-pentyl-2-[6-(1H-tetraazol-5-ylmethoxy)-2-naphthyl]-1H-indole; stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders |
| 12/08/2009 | US7629363 Diaryl substituted pyridinones |
| 12/08/2009 | US7629318 Immunosuppressant compounds, methods and uses related thereto |
| 12/08/2009 | US7629146 A nucleic acid molecule that encodes at least one polypeptide useful as antiangiogenic, tumor suppressive and antimigratory agent; inhibits the migration of cultured cells as well as inhibiting angiogenesis, tumor growth, or any other processes that involve the migration of cells in vivo |
| 12/08/2009 | US7629144 Diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with Secs-1 polypeptides |
| 12/08/2009 | US7628988 Induce cell differentiation; process control |
| 12/08/2009 | CA2381801C Phosphonic acid derivative having inhibitory activity against carboxypeptidase b |
| 12/08/2009 | CA2292757C Therapeutic, prophylactic and diagnostic agent for cancer, useful for characterizing cancer cells with individual properties |
| 12/03/2009 | WO2009145238A1 Immunomodulatory agent and use thereof |
| 12/03/2009 | WO2009144093A1 Hydroxytyrosol benefits mitochondria |